360 related articles for article (PubMed ID: 36367724)
1. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.
Blanchard P; Garden AS; Gunn GB; Rosenthal DI; Morrison WH; Hernandez M; Crutison J; Lee JJ; Ye R; Fuller CD; Mohamed AS; Hutcheson KA; Holliday EB; Thaker NG; Sturgis EM; Kies MS; Zhu XR; Mohan R; Frank SJ
Radiother Oncol; 2016 Jul; 120(1):48-55. PubMed ID: 27342249
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
[TBL] [Abstract][Full Text] [Related]
6. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
7. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Yu NY; DeWees TA; Voss MM; Breen WG; Chiang JS; Ding JX; Daniels TB; Owen D; Olivier KR; Garces YI; Park SS; Sarkaria JN; Yang P; Savvides PS; Ernani V; Liu W; Schild SE; Merrell KW; Sio TT
Clin Lung Cancer; 2022 Dec; 23(8):e526-e535. PubMed ID: 36104272
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia.
Cao J; Zhang X; Jiang B; Chen J; Wang X; Wang L; Sahoo N; Zhu XR; Ye R; Blanchard P; Garden AS; Fuller CD; Gunn GB; Frank SJ
Radiother Oncol; 2021 Jul; 160():32-39. PubMed ID: 33839202
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
13. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Patients With Inoperable Esophageal Squamous Cell Carcinoma Undergoing Curative-Intent Concurrent Chemoradiotherapy.
Chang CL; Lin KC; Chen WM; Shia BC; Wu SY
J Thorac Oncol; 2024 May; 19(5):818-828. PubMed ID: 38154513
[TBL] [Abstract][Full Text] [Related]
16. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
[No Abstract] [Full Text] [Related]
17. A Model-Based Approach to Predict Short-Term Toxicity Benefits With Proton Therapy for Oropharyngeal Cancer.
Rwigema JM; Langendijk JA; Paul van der Laan H; Lukens JN; Swisher-McClure SD; Lin A
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):553-562. PubMed ID: 30625409
[TBL] [Abstract][Full Text] [Related]
18. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.
Frank SJ; Cox JD; Gillin M; Mohan R; Garden AS; Rosenthal DI; Gunn GB; Weber RS; Kies MS; Lewin JS; Munsell MF; Palmer MB; Sahoo N; Zhang X; Liu W; Zhu XR
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):846-53. PubMed ID: 24867532
[TBL] [Abstract][Full Text] [Related]
19. Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.
Ward MC; Ross RB; Koyfman SA; Lorenz R; Lamarre ED; Scharpf J; Burkey BB; Joshi NP; Woody NM; Prendes B; Houston N; Reddy CA; Greskovich JF; Adelstein DJ
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1164-1170. PubMed ID: 27438230
[TBL] [Abstract][Full Text] [Related]
20. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
